You have 9 free searches left this month | for more free features.

Condition

Pompe Disease (1)

Pompe Disease (Late-onset) (1)

Pompe Disease Infantile-Onset (1)

Overall Status

Active, not recruiting (1)

Available (1)

Completed (1)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 3 (1)

Sponsor

Amicus Therapeutics (3)

Collaborator

Intervention

at2221 (3)

atb200 (3)

alglucosidase alfa (1)

Study Documents

Intervention Type

drug (3)

biological (2)

Funder Type

Industry (3)

Study Type

Interventional (2)

Expanded Access (1)

atb200

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Pompe Disease Infantile-Onset Trial in Italy, Taiwan, United States (ATB200, AT2221)

Available

Pompe Disease Infantile-Onset

ATB200
AT2221

Oakland, California
+3 more

Jul 18, 2022

Pompe Disease Trial in Worldwide (ATB200, AT2221)

Active, not recruiting

Pompe Disease

ATB200
AT2221

Phoenix, Arizona
+18 more

Oct 19, 2021

Pompe Disease (Late-onset) Trial in Worldwide (AT2221, alglucosidase alfa, ATB200)

Completed

Pompe Disease (Late-onset)

AT2221
+2 more

Phoenix, Arizona
+72 more

Oct 7, 2021